Q&A With Monika Fischer From Indiana University: Tackling New Challenges In Gastroenterology

Video

Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.

Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.

Monika Fischer, MD, from Indiana University discussed some of the latest research in this field during the annual meeting of the American College of Gastroenterology in Hawaii.

As fecal microbiota transplant becomes a more common procedure to treat patients with gastrointestinal issues new questions are being answered about factors that can affect its success.

Related Videos
Timothy Wilt, MD, MPH | Credit: ACP
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Taha Qazi, MD | Credit: Cleveland Clinic
Taha Qazi, MD | Credit: Cleveland Clinic
Taha Qazi, MD | Cleveland Clinic
© 2024 MJH Life Sciences

All rights reserved.